NASDAQ : ALMR

Alamar Biosciences, Inc. — Company profile

Healthcare · Medical Instruments & Supplies · United States

Last price 30.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.12B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company’s offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

Details

NameAlamar Biosciences, Inc.
SectorHealthcare
IndustryMedical Devices
Employees286
Founded2018
Ipo Date2026-04-17
CeoYuling Luo
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price17.00
IsinUS0109111056
Cusip010911105
Cik2104204
Sic3826

Key executives

NameTitle
Dr. Yuling Luo Ph.D.Co-Founder, Chairman and Chief Executive Officer
Dr. Shiping Chen Ph.D.Co-Founder, Chief Operating Officer and Director
Justin J. McAnearChief Financial Officer
Timothy Ogden White J.D.President
Yiyuan Yin Ph.D.Co-Founder, Vice President of Technology and Acting Secretary
Dr. Xiao-Jun Ma Ph.D.Chief Technology Officer
Dr. Stephen A. Williams M.D., Ph.D.Chief Scientific Officer
Carrie MendivilVice President of Investor Relations and Corporate Communications
John L. Brottem J.D.General Counsel
Alex Forrest-HaySenior Vice President of Sales

Contact

Address47071 Bayside Parkway, Fremont, California 94538, United States
Phone(510) 626-9888
Websitehttps://alamarbio.com